Researchers have discovered the first known Android malware to use generative AI in its execution flow, using Google’s Gemini model to adapt its persistence across different devices. In a report today ...

Add Yahoo as a preferred source to see more of our stories on Google. Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial ...

Designed for production scale, the platform supports parallel operation of multiple miniaturized alignment engines across a single wafer, enabling simultaneous electro-optical probing at multiple test ...

GitHub has released version 0.0.382 of its command-line assistant from single-threaded helper to orchestrated multi-agent system, betting that parallel workflows will accelerate development. GitHub ...

Abstract: Performance optimization is a critical concern in modern game development. Common bottlenecks arise from the high computational demands of game processing, physics simulations, and object ...

It’s used to summarize product requirements, generate test cases, refine test plan documents, suggest potential API tests, and leverage MCP and AI agents to improve test automation scripts. In some ...

Machine learning models are increasingly applied across scientific disciplines, yet their effectiveness often hinges on heuristic decisions such as data transformations, training strategies, and model ...

A new technical paper titled “Massively parallel and universal approximation of nonlinear functions using diffractive processors” was published by researchers at UCLA. “Nonlinear computation is ...

Parallel Wireless, a U.S.-based pioneer in energy-efficient Open RAN solutions, has announced General Availability (GA) of both Trusted Ran Intelligent Controller (T-RIC) and xApp interoperability lab ...

The cap on individual transactions aims to improve block efficiency, reduce DoS risks and lay the groundwork for parallel execution in future upgrades like Glamsterdam. Ethereum is entering the final ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such ...